Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €1.88 EUR
Change Today +0.015 / 0.80%
Volume 1.5K
IM3 On Other Exchanges
As of 3:06 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David M. Goldenberg

Founder and Chairman of the Board,Immunomedics Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. David M. Goldenberg Founded Immunomedics Inc. in July 1982 and served as its Chief Scientific Officer and Chief Medical Officer since June 1, 2007. Dr. Goldenberg serves as the President of Center for Molecular Medicine and Immunology (CMMI) and its clinical unit, Garden State Cancer Center. He serves as an Adjunct Professor of Microbiology and Immunology with the New York Medical College in Valhalla, New York. Dr. Goldenberg served as the Chief Scientific Officer ...

Read Full Background

Corporate Headquarters*

300 The American Road
Morris Plains, New Jersey 07950

United States

Phone: 973-605-8200
Fax: 973-605-8282

Board Members Memberships*

Founder and Chairman of the Board


Unknown/Other Education
University of Chicago, The College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$584,495

Stock Options*

Restricted Stock Awards$1,249,026
All Other Compensation$153,187
Exercisable Options1,393,731
Exercisable Options Value$1,211,309
Unexercisable Options206,572
Unexercisable Options Value$16,790
Total Value of Options$1,228,099
Total Number of Options1,600,303

Total Compensation*

Total Annual Cash Compensation$1,024,085
Total Short Term Compensation$584,495
Other Long Term Compensation$1,402,213
Total Calculated Compensation$2,623,146
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IM3:GR €1.88 EUR +0.015


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOMEDICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at